Meritage Portfolio Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-78,470	Closed	-$2.61M	–	217
2017 Q2	$2.61M	Buy	+78,470	New	+$2.43M	0.27%	145
2016 Q4	–	Sell	-101,262	Closed	-$4.66M	–	200
2016 Q3	$4.66M	Sell	101,262 -3,164	-3%	-$165K	0.51%	101
2016 Q2	$5.25M	Sell	104,426 -1,335	-1%	-$71.1K	0.59%	66
2016 Q1	$5.66M	Sell	105,761 -3,495	-3%	-$205K	0.64%	55
2015 Q4	$7.17M	Sell	109,256 -1,220	-1%	-$75.4K	0.81%	28
2015 Q3	$6.24M	Buy	110,476 +1,153	+1%	+$74.8K	0.72%	38
2015 Q2	$6.46M	Sell	109,323 -1,155	-1%	-$71.3K	0.68%	36
2015 Q1	$6.88M	Buy	110,478 +14	+0%	+$814	0.69%	33
2014 Q4	$6.35M	Sell	110,464 -1,615	-1%	-$90K	0.68%	34
2014 Q3	$6.02M	Sell	112,079 -1,030	-0.9%	-$54.6K	0.69%	38
2014 Q2	$5.93M	Buy	113,109 +3,895	+4%	+$199K	0.65%	46
2014 Q1	$5.77M	Buy	109,214 +2,585	+2%	+$119K	0.69%	45
2013 Q4	$4.27M	Sell	106,629 -5,000	-4%	-$197K	0.53%	94
2013 Q3	$4.22M	Buy	111,629 +1,164	+1%	+$45.4K	0.55%	85
2013 Q2	$4.33M	Buy	+110,465	New	+$4.3M	0.62%	60